Summary
New analogs of diflubenzuron, a benzoylphenyl urea, are tested on their in vitro cytostatic activity against B16 melanoma cells. The following structure-activity relationship was established: substitution by a hydroxylated function at the ortho, meta or para position or by a dimethylamino function at the ortho position of the benzoyl moiety appeared to be necessary for cytostatic activity in vitro. Acetoxy functions at the ortho position or hydroxy functions at the para position of the aniline ring resulted also in active compounds. A number of these benzoylphenyl ureas are selected for in vivo evaluation of antitumor activity on B16 melanoma growing s.c. Although many of the tested benzoylphenyl ureas delayed tumor growth during the first ten days of drug treatment, only a few increased animal life span. The best results (%T/C) were obtained with compounds 5 (127%), 7 (147%), 13 (135%) and 16 (135%), which all have hydroxylated functions in the benzoyl moiety.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Verloop A, Ferrell CD: Benzoylphenyl ureas — a new group of larvicides interfering with chitin deposition. Am Chem Soc Mongr 37:237–270, 1977
Deul DH, DeJong BJ, Kortenbach JAM: Inhibitions of chitin synthesis by two 1-(2,6-disubstitued benzoyl)-3-phenylurea insecticides. Pestic Biochem Physiol 8:98–105, 1978
Meola SM, Mayer RT: Inhibition of cellular proliferation of the imaginai epidermal cells by diflubenzuron in pupae of stable fly. Science 207:985–987, 1980
DeLoach JR, Meola SM, Mayer RT, Thompson JM: Inhibition of DNA Synthesis by diflubenzuron in Pupae of the stable fly Stomoxys calcitrans (1.). Pestic Biochem Physiol 15: 172–180, 1981
Gulka G, Gulka CM, Watabe N: Histopathological effects of diflubenzuron on the Cirripede Crustacean, Balanus eburneus. Arch Environm Contam Toxicol 11:11–16, 1982
Stannard AA, Pulley LT: Tumors of skin and soft tissue. In: Moulton JE (eds) Tumors in domestic animals. University of California Press, Berkeley, 1978, p 62
Norman JO, Meola SM: Inhibition of melanogenesis in B16-F1 melanoma cells after exposure to diflubenzuron. Antimicrob Agents Chemother 23:313–316, 1983
Jenkins VK, Mayer RT, Perry RR: Effects of diflubenzuron on growth of malignant melanoma and skin carcinoma tumors in mice. Invest New Drugs 2:19–27, 1984
Griswold Jr DP: Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents. Cancer Chemotherapy reports Part 2 Vol. 3, No. 1 November 1972
Hill RP, Stanley JA: The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents. Cancer Res 35:1147–1153, 1975
Li HL, Wallace TL, Richard KA, Tracey DE: Mechanism of antitumor action of pyrimidones in the treatment of B16 melanoma and P388 leukemia. Cancer Res 45:532–538, 1985
Vloon WJ, Kruk C, Pandit UK, Hofs HP, McVie JG: Synthesis and biological properties of side-chain-modified bleomycins. J Med Chem 30:20–24, 1987
Dornish JM, Oftebro R: Structure-activity relationship of 1-propargyl-5-halopyrimidin-2-ones. Invest New drugs 1:203–211, 1983
Brana MF, Castellano JM, Roldan CM, Santos A, Vazquez D, Jimenez A: Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8 naphthalic acid. Cancer Chemother Pharmacol 4:61–66, 1980
Temple Jr C, Wheeler GP, Elliott RD, Rose JD, Kussner CL, Comber RN, Montgomery JA: New anticancer agents: synthesis of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7, 8-dihydropteridines). J Med Chem 25:1045–1050, 1982
Schabel Jr FM: The use of tumor growth kinetics in planning “curative” chemotherapy of advanced solid tumors. Cancer Res 29:2384–2389, 1969
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hofs, H.P., McVie, J.G. Effects of benzoylphenyl ureas on growth of B16 melanoma cells in vitro and in vivo . Invest New Drugs 9, 227–232 (1991). https://doi.org/10.1007/BF00176975
Issue Date:
DOI: https://doi.org/10.1007/BF00176975